Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helene Roelofs

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Plos One|January 24, 2014
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?Guido Moll, Annika Hult, Lena von Bahr, et al.
Stem Cells and Development|April 13, 2011
Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migrationMarijke W Maijenburg, Christian Gilissen, Sara M Melief, et al.
Blood|July 11, 2006
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiencyJosé A Borghans, Robbert G Bredius, Mette D Hazenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2013
Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of responseFriso G J Calkoen, Cornelia M Jol-van der Zijde, M Luisa Mearin, et al.
Journal of Translational Medicine|December 11, 2014
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsMarlies E J Reinders, Jonna R Bank, Geertje J Dreyer, et al.
Journal of Translational Medicine|November 6, 2015
Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune studyMarlies E J Reinders, Geertje J Dreyer, Jonna R Bank, et al.
Stem Cells Translational Medicine|January 26, 2013
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I studyMarlies E J Reinders, Johan W de Fijter, Helene Roelofs, et al.
Journal of Cardiovascular Translational Research|August 29, 2013
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-upSander F Rodrigo, Jan van Ramshorst, Georgette E Hoogslag, et al.
Gut|October 6, 2010
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I studyMarjolijn Duijvestein, Anne Christine W Vos, Helene Roelofs, et al.
Journal of Stem Cell Research & Therapy|March 28, 2014
Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive <i>In vitro</i> and in a Humanized Allograft Rejection ModelMarieke Roemeling-van Rhijn, Meriem Khairoun, Sander S Korevaar, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Plos One|January 24, 2014
Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?Guido Moll, Annika Hult, Lena von Bahr, et al.
Stem Cells and Development|April 13, 2011
Nuclear receptors Nur77 and Nurr1 modulate mesenchymal stromal cell migrationMarijke W Maijenburg, Christian Gilissen, Sara M Melief, et al.
Blood|July 11, 2006
Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiencyJosé A Borghans, Robbert G Bredius, Mette D Hazenberg, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 3, 2013
Gastrointestinal acute graft-versus-host disease in children: histology for diagnosis, mesenchymal stromal cells for treatment, and biomarkers for prediction of responseFriso G J Calkoen, Cornelia M Jol-van der Zijde, M Luisa Mearin, et al.
Journal of Translational Medicine|December 11, 2014
Autologous bone marrow derived mesenchymal stromal cell therapy in combination with everolimus to preserve renal structure and function in renal transplant recipientsMarlies E J Reinders, Jonna R Bank, Geertje J Dreyer, et al.
Journal of Translational Medicine|November 6, 2015
Safety of allogeneic bone marrow derived mesenchymal stromal cell therapy in renal transplant recipients: the neptune studyMarlies E J Reinders, Geertje J Dreyer, Jonna R Bank, et al.
Stem Cells Translational Medicine|January 26, 2013
Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I studyMarlies E J Reinders, Johan W de Fijter, Helene Roelofs, et al.
Journal of Cardiovascular Translational Research|August 29, 2013
Intramyocardial injection of autologous bone marrow-derived ex vivo expanded mesenchymal stem cells in acute myocardial infarction patients is feasible and safe up to 5 years of follow-upSander F Rodrigo, Jan van Ramshorst, Georgette E Hoogslag, et al.
Gut|October 6, 2010
Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I studyMarjolijn Duijvestein, Anne Christine W Vos, Helene Roelofs, et al.
Journal of Stem Cell Research & Therapy|March 28, 2014
Human Bone Marrow- and Adipose Tissue-derived Mesenchymal Stromal Cells are Immunosuppressive <i>In vitro</i> and in a Humanized Allograft Rejection ModelMarieke Roemeling-van Rhijn, Meriem Khairoun, Sander S Korevaar, et al.
Pageof 5